DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zyrtec (Cetirizine) - Adverse Event Reports - Hospitalization - Drug Ineffective

 



Index of reports > Cases resulting in hospitalization (23) > Cases with Drug Ineffective (3)

Below is the selection of adverse event reports related to Zyrtec (Cetirizine) that includes cases resulting in hospitalization where reactions include drug ineffective.

Adverse event in female receiving Zyrtec (Cetirizine)

Reported by a physician from United States on 2007-04-28

Patient: female, weighing 99.8 kg (219.6 pounds)

Adverse reactions / side effects: Marfan's Syndrome, Tinnitus, Contusion, Arterial Disorder, Drug Ineffective, Trigeminal Neuralgia, Pain, Drug Interaction, High Risk Pregnancy, Incontinence, Coronary Artery Occlusion, Blood Cholesterol Increased, Depression, Myocardial Infarction, Fluid Retention, Malaria, Angina Pectoris, Ear Disorder, Ear Infection, Coronary Artery Disease, Uterine Enlargement, Migraine With Aura, Sick Sinus Syndrome, Impaired Healing, Dehydration, Dressler's Syndrome, Multiple Allergies, Hypertension, Neuralgia

Adverse event resulted in: hospitalization

Suspect drug(s):
Celebrex
    Indication: Pain

Zyrtec

Relpax

Xalatan

Azithromycin

Other drugs received by patient possibly interacting with the suspect drug:
Lyrica
    Indication: Neuralgia

Lasix

Nexium

Other drugs received by patient: Tikosyn; Tikosyn; Atenolol; Plendil; Nitroglycerin; Plavix; Acetylsalicylic Acid SRT; Zetia; Tylenol W / Codeine NO. 3; Zantac; Tetracycline; E-Mycin; Statins; Antidepressants; Antiepileptics; Analgesics; Nitrotab; Penicillin; Clinoril; Demerol; Oxycodone HCL; Darvon; Caffeine; Percocet; Menthol; ALL Other Therapeutic Products; ALL Other Therapeutic Products; Iodine; Sulfonamides; Niacin



Adverse event in 66 year old female receiving Zyrtec (Cetirizine)

Reported by a physician from France on 2007-03-15

Patient: 66 year old female

Adverse reactions / side effects: Drug Ineffective, Prothrombin Time Abnormal, International Normalised Ratio Decreased, Pulmonary Embolism

Adverse event resulted in: hospitalization

Suspect drug(s):
Zyrtec
    Dosage: daily dose:10mg
    Administration route: Oral
    Indication: Ill-Defined Disorder
    Start date: 2004-04-30
    End date: 2004-05-07

Quinapril Hydrochloride and Hydrochlorothiazde
    Dosage: text:0.5 dose
    Administration route: Oral
    Indication: Essential Hypertension

Fluindione
    Dosage: daily dose:20mg
    Administration route: Oral
    Indication: Pulmonary Embolism
    Start date: 2004-04-28
    End date: 2004-05-01

Clonazepam
    Dosage: text:0.5 dose
    Administration route: Oral
    Indication: Ill-Defined Disorder

Soprol
    Administration route: Oral
    Indication: Essential Hypertension



Adverse event in female receiving Zyrtec (Cetirizine)

Reported by a consumer/non-health professional from United States on 2007-03-09

Patient: female, weighing 50.8 kg (111.8 pounds)

Adverse reactions / side effects: Hypersensitivity, Nausea, Drug Ineffective, Headache, Convulsion, Liver Disorder, Suicidal Ideation, Weight Increased, Dysstasia, Malaise, Pharyngeal Oedema, Hepatic Cyst, Insomnia, Abdominal Distension, Dizziness, Depression, Oedema Mouth, Feeling Abnormal, Drug Interaction Inhibition

Adverse event resulted in: hospitalization

Suspect drug(s):
Lipitor
    Indication: Blood Cholesterol Increased

Zyrtec
    Indication: Multiple Allergies

Xanax
    Indication: Depression

Benadryl

Other drugs received by patient possibly interacting with the suspect drug:
Chantix
    Indication: Smoking Cessation Therapy
    Start date: 2007-02-01
    End date: 2007-02-01

Contrast Media
    Indication: Computerised Tomogram
    Start date: 2007-02-01
    End date: 2007-02-01

Other drugs received by patient: Crestor; Zocor; ALL Other Therapeutic Products; Dyazide; Oxygen; Zelnorm; Prevacid

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009